Efficacy and Safety of Skincare Serum and Cream for Anti-aging of Facial Skin
Trial statusNot yet recruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age18-50
SponsorGoldman, Butterwick, Fitzpatrick and Groff
About this trial
The primary objective of this study is to assess the efficacy and safety of combination therapy of BABOR® Ultimate ECM Repair Serum and the BABOR® Cure Cream for the improvement of anti-aging through the use of investigator assessments, subject questionnaires/assessments, photography, skin imaging, and reported adverse reactions.
Eligibility criteria
Qualifiers
Men and women between the ages of 18 and 50 years old (inclusive).
Subjects must be able and willing to provide written informed consent and photography release.
Class I-II of Wrinkling on the Fitzpatrick-Goldman Classification of Wrinkling and Degree of Elastosis Scale
Score 1-6 of Degree of Elastosis on the Fitzpatrick-Goldman Classification of Wrinkling and Degree of Elastosis Scale
Disqualifiers
Subjects who are pregnant, planning pregnancy during the course of the study, or breastfeeding.
Subjects with an active bacterial, fungal, or viral infection in the treatment area
Subjects with a significant history or current evidence of a medical, psychological or other disorder that, in the investigator's opinion, would preclude enrollment into the study.
Subjects receiving any topical products containing tretinoins or derivatives, alpha-hydroxy acids, salicylic acid, and vitamins C or E (includes derivatives thereof) on the face within 14 days prior to or during the study period, other than the study products.
Trial design
Treatments tested in this trial
- Babor Ultimate ECM Repair Serum
- Babor Cure Cream
Treatment groups
18 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Goldman, Butterwick, Fitzpatrick and Groff
Lead sponsor
Babor Americas
Collaborator
Source ClinicalTrials.gov